Marc Tessier-Lavigne

At-a-Glance

Co-founder, CEO, and chair of Xaira Therapeutics, an AI biotechnology firm.
Served as the 11th president of Stanford University from 2016 until 2023.
Served as the 10th president of Rockefeller University in New York City from 2011 to 2016.
Co-founded Denali Therapeutics in 2015 and joined its board.
Formerly Executive Vice President for Research and Chief Scientific Officer at Genentech.
Joined the boards of directors of Agios Pharmaceuticals, Regeneron Pharmaceuticals, and Pfizer in 2011, and Juno Therapeutics in 2014.

Biography

Marc Tessier-Lavigne is a Canadian-American neuroscientist who serves as the co-founder, CEO, and chair of Xaira Therapeutics, an AI biotechnology firm. He is also a biology professor at Stanford University. Prior to his current role, he was the 11th president of Stanford University from 2016 until his resignation in 2023.